Trial Profile
First‑in‑Human Phase I Study assessing Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Evocalcet (Primary)
- Indications Hyperparathyroidism
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- 07 Sep 2018 New trial record
- 30 Aug 2018 Results published in the Clinical Drug Investigation